Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 1949-1967
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.1949
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.1949
Figure 3 Protein levels of ELL-associated factor 2, phosphorylated-signal transducer and activator of transcription 3, and transforming growth factor-β1 in colorectal cancer cell lines (SW480, RKO, HCT116, HT29, and HIEC) and normal colorectal epithelial cells (NCM460) by western blot assay.
A: Western blot results of proteins in in colorectal cancer cell lines (SW480, RKO, HCT116, HT29, and HIEC) and normal colorectal epithelial cells (NCM460); B: Relative expression of the proteins. The data are shown as the mean ± SD. aP < 0.05, bP < 0.001. p-STAT3: Phosphorylated-signal transducer and activator of transcription 3; TGF-β1: Transforming growth factor-β1; EAF2: ELL-associated factor 2; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
- Citation: Feng ML, Wu C, Zhang HJ, Zhou H, Jiao TW, Liu MY, Sun MJ. Overexpression of ELL-associated factor 2 suppresses invasion, migration, and angiogenesis in colorectal cancer. World J Gastrointest Oncol 2022; 14(10): 1949-1967
- URL: https://www.wjgnet.com/1948-5204/full/v14/i10/1949.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i10.1949